In this webinar we described the rationale and development process of the interim guidance on diagnostic testing for Ebola and Marburg virus diseases (EBOD and MVD), and looked into critical testing aspects including type and timing of sampling and testing, workflow in a field laboratory and biosafety requirements. We heard from colleagues in Rwanda on scaling up testing capacities for an outbreak response.
We will welcome:
Dr Anaïs Legand (WHO Headquarters)
Dr Lisa Carter (WHO Headquarters)
Dr Sophie Durrafour (Bernhard Nocht Institute for Tropical Medicine, Germany)
Dr Isabelle Mukagatare (Rwanda Biomedical Center, Rwanda)
Launched in May 2020, this knowledge sharing platform aims to enhance WHO guidance dissemination and best practice sharing among public health laboratories globally. WHO is grateful to the technical and financial partners who have helped to support and sustain this webinar series.